Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Spotlight on Proffered Papers Session 1

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 2 of 2
Spotlight on Proffered Papers Session 1
Drugs in the curative RCHOP combination exhibit low cross-resistance but not pharmacologic synergy
Adam C Palmer
Harvard Medical School, Boston, MA, United States
from 2018 Advances in Malignant Lymphoma conference on June 23, 2018 11:00 AM-11:30 AM
Spotlight on Proffered Papers Session 1
  •  
  • Permission not
    granted for presentation
  •  
  •  
MHC class II expression is associated with a distinct mutational profile and immune cell landscape of the microenvironment in GCB-DLBCL
Daisuke Ennishi
BC Cancer Agency, Vancouver, BC, Canada
from 2018 Advances in Malignant Lymphoma conference on June 23, 2018 11:00 AM-11:30 AM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 2 of 2